Widespread metastases in small cell carcinoma of the prostate on FDG PET/CT.
A 72-year-old man recently diagnosed with a small cell carcinoma of the prostate was referred for staging of the primary malignancy. F-18-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography and computed tomography (PET/CT) revealed extensive hypermetabolic metastatic involvement of the liver, multiple small metastatic nodules in the lungs, and a solitary bone metastasis to the left scapula, in addition to increased FDG uptake in the enlarged prostate. Serum prostate-specific antigen level was within normal limits. Although FDG PET is not a helpful imaging method for evaluating prostatic adenocarcinoma, it may be useful in staging of small cell carcinoma of the prostate.
Yilmaz
Mustafa
M
Department of Nuclear Medicine, University of Gaziantep School of Medicine, Gaziantep, Turkey. yilmazmustafa@yahoo.com
Celen
Zeki
Z
Sevinc
Alper
A
Karakok
Metin
M
D000368:Aged; D018288:Carcinoma, Small Cell / Q000000981:diagnostic imaging / Q000473:pathology*; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis / Q000000981:diagnostic imaging*; D049268:Positron-Emission Tomography; D011471:Prostatic Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology*; D014057:Tomography, X-Ray Computed
D019788:Fluorodeoxyglucose F18